AMP kinase-related kinase NUAK2 affects tumor growth, migration, and clinical outcome of human melanoma

Proceedings of the National Academy of Sciences of the United States of America

Volumn 108, Issue 16, 2011, Pages 6597-6602

  Namiki, Takeshi ^a,f   Tanemura, Atsushi ^b   Valencia, Julio C ^a   Coelho, Sergio G ^a   Passeron, Thierry ^a   Kawaguchi, Masakazu ^a   Vieira, Wilfred D ^a   Ishikawa, Masashi ^c   Nishijima, Wataru ^c   Izumo, Toshiyuki ^c   Kaneko, Yasuhiko ^c   Katayama, Ichiro ^b   Yamaguchi, Yuji ^a,d   Yin, Lanlan ^a   Polley, Eric C ^a   Liu, Hongfang ^a,g   Kawakami, Yutaka ^e   Eishi, Yoshinobu ^f   Takahashi, Eishi ^f   Yokozeki, Hiroo ^f   Hearing, Vincent J ^a   more..

^a NATIONAL CANCER INSTITUTE   (United States)

^b OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^c SAITAMA CANCER CENTER   (Japan)

^d NAGOYA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICAL SCIENCES   (Japan)

^e KEIO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^f TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

^g Mayo Clinic   (United States)

Author keywords

Chromosome 1q; Sucrose nonfermenting like kinase

Indexed keywords

ADENYLATE KINASE; MAMMALIAN TARGET OF RAPAMYCIN; NUAK2 PROTEIN; UNCLASSIFIED DRUG;

ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER INHIBITION; CANCER RELAPSE; CARCINOGENESIS; CELL CYCLE S PHASE; CHROMOSOME 1Q; CHROMOSOME ABERRATION; COMPARATIVE GENOMIC HYBRIDIZATION; COPY NUMBER VARIATION; CYTOGENETICS; DISEASE FREE SURVIVAL; GENE AMPLIFICATION; GENE IDENTIFICATION; GENE LOCUS; HUMAN; IMMUNOHISTOCHEMISTRY; IN VIVO STUDY; KAPLAN MEIER METHOD; MAJOR CLINICAL STUDY; MELANOMA; MELANOMA CELL; MELANOMAGENESIS; METASTASIS; OVERALL SURVIVAL; PRIORITY JOURNAL; PROGNOSIS; PROPORTIONAL HAZARDS MODEL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; REGRESSION ANALYSIS; RISK ASSESSMENT; SENESCENCE; TUMOR GROWTH;

ANIMALS; CELL AGING; CELL MOVEMENT; DISEASE-FREE SURVIVAL; FEMALE; GENE EXPRESSION REGULATION, ENZYMOLOGIC; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE KNOCKDOWN TECHNIQUES; GENETIC LOCI; GENOME-WIDE ASSOCIATION STUDY; HUMANS; MALE; MELANOMA; MICE; MICE, NUDE; NEOPLASM PROTEINS; PROTEIN-SERINE-THREONINE KINASES; S PHASE; SURVIVAL RATE; TOR SERINE-THREONINE KINASES;

MAMMALIA; MUS;

EID: 79955627781     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.1007694108     Document Type: Article

References (37)

1. Sidransky D (2002) Emerging molecular markers of cancer. Nat Rev Cancer 2: 210-219.
2. Hunter T (2007) Treatment for chronic myelogenous leukemia: The long road to imatinib. J Clin Invest 117:2036-2043.
3. Kaneko Y, et al. (1982) Correlation of karyotype with clinical features in acute lymphoblastic leukemia. Cancer Res 42:2918-2929. (Pubitemid 12085769)
4. Albertson DG, Collins C, McCormick F, Gray JW (2003) Chromosome aberrations in solid tumors. Nat Genet 34:369-376. (Pubitemid 36935328)
5. Mertens F, Johansson B, Höglund M, Mitelman F (1997) Chromosomal imbalance maps of malignant solid tumors: A cytogenetic survey of 3185 neoplasms. Cancer Res 57: 2765-2780. (Pubitemid 27283792)
6. Pinkel D, et al. (1998) High resolution analysis of DNA copy number variation using comparative genomic hybridization to microarrays. Nat Genet 20:207-211. (Pubitemid 28455458)
7. Bittner M, et al. (2000) Molecular classification of cutaneous malignant melanoma by gene expression profiling. Nature 406:536-540. (Pubitemid 30625740)
8. Dissanayake SK, et al. (2007) The Wnt5A/protein kinase C pathway mediates motility in melanoma cells via the inhibition of metastasis suppressors and initiation of an epithelial to mesenchymal transition. J Biol Chem 282:17259-17271. (Pubitemid 47093253)
9. Carr KM, Bittner M, Trent JM (2003) Gene-expression profiling in human cutaneous melanoma. Oncogene 22:3076-3080. (Pubitemid 36713758)
10. Clark EA, Golub TR, Lander ES, Hynes RO (2000) Genomic analysis of metastasis reveals an essential role for RhoC. Nature 406:532-535. (Pubitemid 30625739)
11. Orsetti B, et al. (2006) Genetic profiling of chromosome 1 in breast cancer: Mapping of regions of gains and losses and identification of candidate genes on 1q. Br J Cancer 95:1439-1447. (Pubitemid 44760099)
12. Corson TW, Huang A, Tsao MS, Gallie BL (2005) KIF14 is a candidate oncogene in the 1q minimal region of genomic gain in multiple cancers. Oncogene 24: 4741-4753. (Pubitemid 41076292)
13. Gratias S, et al. (2005) Genomic gains on chromosome 1q in retinoblastoma: Consequences on gene expression and association with clinical manifestation. Int J Cancer 116:555-563. (Pubitemid 41099191)
14. Kim TM, et al. (2008) Clinical implication of recurrent copy number alterations in hepatocellular carcinoma and putative oncogenes in recurrent gains on 1q. Int J Cancer 123:2808-2815.
15. Tai AL, et al. (2004) Recurrent chromosomal imbalances in nonsmall cell lung carcinoma: The association between 1q amplification and tumor recurrence. Cancer 100:1918-1927. (Pubitemid 38529570)
16. Wilting SM, et al. (2008) Integrated genomic and transcriptional profiling identifies chromosomal loci with altered gene expression in cervical cancer. Genes Chromosomes Cancer 47:890-905.
17. Trent JM, Thompson FH,Meyskens FL, Jr. (1989) Identification of a recurring translocation site involving chromosome 6 in human malignant melanoma. Cancer Res 49:420-423. (Pubitemid 19049537)
18. Thompson FH, et al. (1995) Cytogenetics of 158 patients with regional or disseminated melanoma. Subset analysis of near-diploid and simple karyotypes. Cancer Genet Cytogenet 83:93-104.
19. Namiki T, et al. (2005) Genomic alterations in primary cutaneous melanomas detected by metaphase comparative genomic hybridization with laser capture or manual microdissection: 6p gains may predict poor outcome. Cancer Genet Cytogenet 157: 1-11. (Pubitemid 40164851)
20. Lizcano JM, et al. (2004) LKB1 is a master kinase that activates 13 kinases of the AMPK subfamily, including MARK/PAR-1. EMBO J 23:833-843. (Pubitemid 38418750)
21. Legembre P, Schickel R, Barnhart BC, Peter ME (2004) Identification of SNF1/AMP kinase-related kinase as an NF-kappaB-regulated anti-apoptotic kinase involved in CD95-induced motility and invasiveness. J Biol Chem 279:46742-46747. (Pubitemid 39518322)
22. Lefebvre DL, et al. (2001) Identification and characterization of a novel sucrose-nonfermenting protein kinase/AMP-activated protein kinase-related protein kinase, SNARK. Biochem J 355:297-305. (Pubitemid 32397787)
23. Zagórska A, et al. (2010) New roles for the LKB1-NUAK pathway in controlling myosin phosphatase complexes and cell adhesion. Sci Signal, 10.1126/scisignal.2000616.
24. Hardie DG (2007) AMP-activated/SNF1 protein kinases: Conserved guardians of cellular energy. Nat Rev Mol Cell Biol 8:774-785.
25. Martin MJ, Carling D, Marais R (2009) Taking the stress out of melanoma. Cancer Cell 15:163-164.
26. Ashrafian H (2006) Cancer's sweet tooth: The Janus effect of glucose metabolism in tumorigenesis. Lancet 367:618-621.
27. Zheng B, et al. (2009) Oncogenic B-RAF negatively regulates the tumor suppressor LKB1 to promote melanoma cell proliferation. Mol Cell 33:237-247.
28. Esteve-Puig R, Canals F, Colomé N, Merlino G, Recio JA (2009) Uncoupling of the LKB1-AMPKalpha energy sensor pathway by growth factors and oncogenic BRAF. PLoS ONE 4:e4771.
29. Heagerty PJ, Lumley T, Pepe MS (2000) Time-dependent ROC curves for censored survival data and a diagnostic marker. Biometrics 56:337-344. (Pubitemid 30422619)
30. Heagerty PJ, Zheng Y (2005) Survival model predictive accuracy and ROC curves. Biometrics 61:92-105. (Pubitemid 40380968)
31. Yamaguchi Y, et al. (2004) Mesenchymal-epithelial interactions in the skin: Increased expression of dickkopf1 by palmoplantar fibroblasts inhibits melanocyte growth and differentiation. J Cell Biol 165:275-285. (Pubitemid 38544530)
32. Yamaguchi Y, et al. (2007) The effects of dickkopf 1 on gene expression and Wnt signaling by melanocytes: Mechanisms underlying its suppression of melanocyte function and proliferation. J Invest Dermatol 127:1217-1225. (Pubitemid 46625128)
33. Yamamoto H, et al. (2008) Identification of a novel substrate for TNFalpha-induced kinase NUAK2. Biochem Biophys Res Commun 365:541-547. (Pubitemid 350181689)
34. Tsuchihara K, et al. (2008) Susceptibility of Snark-deficient mice to azoxymethane-induced colorectal tumorigenesis and the formation of aberrant crypt foci. Cancer Sci 99:677-682. (Pubitemid 351448070)
35. Gray-Schopfer VC, Wellbrock C, Marais R (2007) Melanoma biology and new targeted therapy. Nature 445:851-857.
36. Bauer AJ, Stratakis CA (2005) The lentiginoses: Cutaneous markers of systemic disease and a window to new aspects of tumourigenesis. J Med Genet 42:801-810. (Pubitemid 41598187)
37. Wong SS, Rajakulendran S (1996) Peutz-Jeghers syndrome associated with primary malignant melanoma of the rectum. Br J Dermatol 135:439-442. (Pubitemid 26297842)